Connect with us


Memory tracking – the emerging tool in dementia fight

Avatar photo



A Californian health tech firm which develops products that address neurological disorders including dementia has launched a series of memory-boosting apps.

Leucadia Therapeutics is launching eight apps that help exercise memory and cognition, including a personalised memory tracker called ProCogny.

ProCogny allows users to play memory-intensive puzzles and games, daily brain boost collections of mini-puzzles, and a non-clinical version of the Leucadia Memory Test (LMT).

Leucadia’s team developed ProCogny to assess memory and cognition in its Alzheimer’s disease study (projectcribrose.com).

Having seen how much participants enjoyed the games, the team added in-house AI to produce the memory tracker.

The app includes games and puzzles that exercise different facets of memory, such as word recall, reasoning, alternating tasks, matching, object recognition, pattern recognition, and spatiotemporal memory.

It also features ‘daily brain boosts’ – rotating collections of mini-puzzles tailored to focus on areas that users had problems within the memory test. 

Many health trackers count steps and measure physical activity, but few solutions focus on exercising memory.

Leucadia CEO Douglas Ethell said: “ProCogny is a fun way to exercise their memory by playing puzzles. If this app gives someone a good start to their day and they feel good about exercising their memory, it’s a win-win.”

Leucadia is also releasing standalone games from its memory tracker: Infinite Mahjong, Iconic Sudoku, Word Recall, Connectors, Image Recall, Pattern Busters, and Speed Demon. 

Leucadia is a California-based company working on neurological disorders, using machine learning, clinical imaging, and behavioural testing.

LMT is part of the company’s approach to addressing the underlying cause of Alzheimer’s disease. It is hoped that it could help to predict who will get the disease and when, years before cognitive impairment begins.

Leucadia’s Deep Learning algorithm uses CT scans, LMT, and other measures.

Clinical trials with Leucadia’s interventional device Arethusta, a prophylactic device that restores the clearance of toxins that may seed Alzheimer’s disease pathology, are due to begin in 2022.

Continue Reading
1 Comment

1 Comment

  1. Pingback: Potential treatment for inherited dementia - Health Tech World

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories